Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characteristics and Prognosis Factors of Pneumocystis jirovecii Pneumonia According to Underlying Disease: A Retrospective Multicenter Study.
Lécuyer R, Issa N, Camou F, Lavergne RA, Gabriel F, Morio F, Canet E, Raffi F, Boutoille D, Cady A, Gousseff M, Crabol Y, Néel A, Tessoulin B, Gaborit B; PRONOCYSTIS Study Group. Lécuyer R, et al. Among authors: gaborit b. Chest. 2024 Jun;165(6):1319-1329. doi: 10.1016/j.chest.2024.01.015. Epub 2024 Jan 11. Chest. 2024. PMID: 38215935 Free article.
Sex-based differences in ICU management and outcomes of immunocompromised patients: A post hoc analysis of the prospective multicenter multinational Efraim cohort.
Mehta S, Azoulay E, Munshi L, Demoule A, Perner A, Meyhoff TS, Bauer PR, Metaxa V, Pène F, Girault C, Soares M, Taccone FS, Antonelli M, Barbier F, Barratt-Due A, Bruneel F, Bukan RB, Burghi G, Chevret S, Gaborit B, Hemelaar P, Kouatchet A, Landburg PP, Lemiale V, Martin-Loeches I, Mokart D, Moreau AS, Montini L, Nielsen LB, Pickkers P, Rello J, Rusinova K, Salluh J, Schellongowski P, Souppart V, Terzi N, Valkonen M, van de Louw A, Darmon M; Efraim investigators and the Nine-I study group. Mehta S, et al. Among authors: gaborit b. J Crit Care. 2025 Jun 28;89:155149. doi: 10.1016/j.jcrc.2025.155149. Online ahead of print. J Crit Care. 2025. PMID: 40582132
Real-world study of Ceftazidime-Avibactam for the treatment of disease caused by bacteria: a plain language summary.
Soriano A, Montravers P, Bassetti M, Klyasova G, Daikos G, Irani P, Stone G, Peeters P, Shah M, Hulin C, Gaborit B, Kourbeti I, Menichetti F, Perez-Rodriguez MT, Pletz MW, Sanchez M, Trompa I, Verma A, de Figueiredo MLN, Charbonneau C. Soriano A, et al. Among authors: gaborit b. Future Microbiol. 2025 Jun 20:1-7. doi: 10.1080/17460913.2025.2515005. Online ahead of print. Future Microbiol. 2025. PMID: 40539324
sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trial.
Smadja DM, Massonnaud CR, Philippe A, Rosa M, Luneau S, Rauch A, Peiffer-Smadja N, Gagneux-Brunon A, Poissy J, Gruest M, Ung A, Pourcher V, Raffi F, Piroth L, Bouiller K, Esperou H, Delmas C, Belhadi D, Diallo A, Saillard J, Dechanet A, Mercier N, Dupont A, Lescure FX, Goehringer F, Jaureguiberry S, Danion F, Tolsma V, Cabie A, Courjon J, Leroy S, Mootien J, Mourvillier B, Gallien S, Lanoix JP, Botelho-Nevers E, Wallet F, Richard JC, Reuter J, Gaymard A, Greil R, Martin-Blondel G, Andrejak C, Yazdanpanah Y, Burdet C, Diehl JL, Hites M, Ader F, Susen S, Mentré F, Dupont A; Discovery Study Group. Smadja DM, et al. Sci Rep. 2025 Apr 24;15(1):14348. doi: 10.1038/s41598-025-95122-7. Sci Rep. 2025. PMID: 40274842 Free PMC article. Clinical Trial.
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes.
McGuire DK, Marx N, Mulvagh SL, Deanfield JE, Inzucchi SE, Pop-Busui R, Mann JFE, Emerson SS, Poulter NR, Engelmann MDM, Ripa MS, Hovingh GK, Brown-Frandsen K, Bain SC, Cavender MA, Gislum M, David JP, Buse JB; SOUL Study Group. McGuire DK, et al. N Engl J Med. 2025 May 29;392(20):2001-2012. doi: 10.1056/NEJMoa2501006. Epub 2025 Mar 29. N Engl J Med. 2025. PMID: 40162642 Clinical Trial.
Mycoplasma pneumoniae infection in adult inpatients during the 2023-24 outbreak in France (MYCADO): a national, retrospective, observational study.
Gavaud A, Holub M, Asquier-Khati A, Faure K, Leautez-Nainville S, Le Moal G, Goehringer F, Luque Paz D, Arnould B, Gerber V, Martin-Blondel G, Declerck C, Gazaignes S, Blanchi S, Loubet P, Mrozek N, Perpoint T, Cresta M, Mailhe M, Bleibtreu A, Cazanave C, Bébéar C, Pourcher V, Tubach F, Palich R; MYCADO Study Group. Gavaud A, et al. Lancet Infect Dis. 2025 Jul;25(7):801-812. doi: 10.1016/S1473-3099(24)00805-3. Epub 2025 Feb 19. Lancet Infect Dis. 2025. PMID: 39986287
Semaglutide 2.4 mg in French people living with Class 3 obesity and comorbidities: Baseline characteristics and real-world safety data.
Disse E, Aron-Wisnewsky J, Jacobi D, Clément K, Laville M, Gauthier C, Pattou F, Molleville J, Akerib M, Jubin L, Gatta-Cherifi B, Gaborit B, Montastier E, Stenard F, Carette C, Achamrah N, Avignon A, Czernichow S; SEMAFEAP Study Group. Disse E, et al. Among authors: gaborit b. Diabetes Metab. 2025 May;51(3):101625. doi: 10.1016/j.diabet.2025.101625. Epub 2025 Feb 17. Diabetes Metab. 2025. PMID: 39971183
Real-world multicentre study of cefiderocol treatment of immunocompromised patients with infections caused by multidrug-resistant Gram-negative bacteria: CEFI-ID.
Soueges S, Faure E, Parize P, Lanternier-Dessap F, Lecuyer H, Huynh A, Martin-Blondel G, Gaborit B, Blot M, Magallon A, Blanchard E, Brousse X, Lahouati M, Brunel AS, Le Banner E, Camelena F, Larcher R, Pantel A, Melica G, Razazi K, Danion F, Schramm F, Dumitrescu O, Hoellinger B, Ader F; G2I (Groupe Immunodepression et Infections) network. Soueges S, et al. Among authors: gaborit b. J Infect. 2025 Jan;90(1):106376. doi: 10.1016/j.jinf.2024.106376. Epub 2024 Dec 15. J Infect. 2025. PMID: 39681233 Free article.
190 results